Exploring ASPC 2025: Innovations in Preventive Cardiology
In this episode we bring you highlights of ASPC 2025, focusing on innovative training, key participants, and significant advancements in preventive cardiology. The discussion covers insights from the ASPC Training Academy, notable award presentations, and the growing importance of lipoprotein(a) in cardiovascular risk assessment. Debates on systolic blood pressure goals, the role of colchicine in secondary prevention, and the comparison between APO-B and LDL-C measurements are explored. The conversation concludes with a look at the potential of AI technology in enhancing preventive cardiology practices. This conversation delves into the intersection of generative AI and healthcare, exploring its potential benefits and challenges, particularly in preventive cardiology. The discussion highlights the importance of health equity, the role of polygenic risk scores and imaging in patient assessment, and the ongoing debate surrounding hormone replacement therapy. The speakers also reflect on career development in preventive cardiology, emphasizing the diverse paths available. Additionally, the conversation expands the scope of cardiovascular prevention to include heart failure and atrial fibrillation, while also addressing the unique cardiovascular risks faced by women throughout their lives. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.